NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 28, 2024 $75.00 +94.91% $94.50 V 79.37% 1
Feb 12, 2024 $30.11 -1.53% $31.73 X 94.91% 0
Feb 12, 2024 $29.83 -2.45% $31.73 X 94.03% 0
Feb 12, 2024 Bullish $31.73 V 1
JS JS Pro
Jan 10, 2024 $22.26 +3.25% $21.67 V 97.28% 1
AlexVel AlexVel Pro
Jan 10, 2024 $21.43 -0.60% $21.67 X 98.89% 1
Jan 10, 2024 $21.06 -2.34% $21.67 X 97.16% 0
Jan 10, 2024 $21.24 -1.46% $21.67 X 98.04% 0
Apr 28, 2023 $20.14 +2.72% $21.31 V 94.52% 1
Apr 28, 2023 $19.94 +1.70% $21.31 V 93.59% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE